# Efavirenz

NDC: 65862-049
Generic name: Efavirenz
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180921

FDA application: ANDA077673

## Active ingredients

- EFAVIRENZ: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-049"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-049
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5eedb5d-4cab-4056-a14a-ffdf67701355